Overview
Announcements

Ordinary Adjustment | Solactive Genomics Index | Effective Date 11th November 2024

Solactive Genomics v2 Index:

In the ordinary adjustment, the following composition will be implemented effective open 11th November 2024:

VERTEX PHARMACEUTICALS INC
GILEAD SCIENCES INC
AGILENT TECHNOLOGIES INC
ALNYLAM PHARMACEUTICALS INC
BIONTECH SE
ILLUMINA INC
MODERNA INC
NATERA INC
BIOMARIN PHARMACEUTICAL INC
SAREPTA THERAPEUTICS INC
BIO-TECHNE CORP
QIAGEN NV
LEGEND BIOTECH CORP
AVIDITY BIOSCIENCES INC
ULTRAGENYX PHARMACEUTICAL INC
CRISPR THERAPEUTICS AG
VERACYTE INC
ARROWHEAD PHARMACEUTICALS INC
INTELLIA THERAPEUTICS INC
MYRIAD GENETICS INC
GENSCRIPT BIOTECH CORP
BEAM THERAPEUTICS INC
10X GENOMICS INC
ROCKET PHARMACEUTICALS INC
CAREDX INC
MARAVAI LIFESCIENCES HOLDINGS INC
VIR BIOTECHNOLOGY INC
SANA BIOTECHNOLOGY INC
PACIFIC BIOSCIENCES OF CALIFORNIA INC
REGENXBIO INC
ALLOGENE THERAPEUTICS INC
FULGENT GENETICS INC
VERVE THERAPEUTICS INC
SANGAMO THERAPEUTICS INC
UNIQURE B.V.
EDITAS MEDICINE INC
2SEVENTY BIO INC-W/I
POSEIDA THERAPEUTICS INC
CARIBOU BIOSCIENCES INC
LYELL IMMUNOPHARMA INC